Stonebridge Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Stonebridge Financial Group's VRTX Position: Q3 2026 in Review
Stonebridge Financial Group sold out of Vertex Pharmaceuticals (VRTX) in Q3 2026, closing a stake of 465 shares — an estimated $230K sold.
Stonebridge Financial Group first reported a position in VRTX in Q2 2026 and held it in 1 quarter. The position peaked at $230K in Q2 2026. 1,793 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Stonebridge Financial Group reported no remaining Vertex Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Stonebridge Financial Group sold 465 Vertex Pharmaceuticals shares in Q3 2026, an estimated $230K.
- Stonebridge Financial Group first reported a position in Vertex Pharmaceuticals in Q2 2026 and held it in 1 quarter.
- Stonebridge Financial Group's Vertex Pharmaceuticals position peaked at $230K in Q2 2026.
- 1,793 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Stonebridge Financial Group's 13F filing for Q3 2026, filed 12 Nov 2026.